Medicines for the mind: Policy-based "Pull" incentives for creating breakthrough CNS drugs

Keyphrases

• CNS Drugs 100%
• Neuroscience 100%
• Policy-based 100%
• Pull Incentives 100%
• Pharmaceutical Companies 50%
• Therapeutic Approaches 50%
• Therapeutic Area 50%
• Disease Mechanisms 50%
• Neuroscience Research 50%
• Policy Change 50%
• Nervous System Diseases 50%
• Brain Diseases 50%
• Underlying Risk 50%
• Calculus 50%
• Weak Area 50%
• Risk-reward 50%
• Market Returns 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Diseases 100%
• Brain Disease 50%
• Stone Formation 50%

Neuroscience

• Neuroscience 100%
• Nervous System Disorder 33%
• Brain Disease 33%